These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27086975)

  • 21. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord.
    Gilmore CP; Donaldson I; Bö L; Owens T; Lowe J; Evangelou N
    J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):182-7. PubMed ID: 18829630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement is activated in progressive multiple sclerosis cortical grey matter lesions.
    Watkins LM; Neal JW; Loveless S; Michailidou I; Ramaglia V; Rees MI; Reynolds R; Robertson NP; Morgan BP; Howell OW
    J Neuroinflammation; 2016 Jun; 13(1):161. PubMed ID: 27333900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical Remyelination Is Heterogeneous in Multiple Sclerosis.
    Strijbis EMM; Kooi EJ; van der Valk P; Geurts JJG
    J Neuropathol Exp Neurol; 2017 May; 76(5):390-401. PubMed ID: 28521040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis.
    Loveless S; Neal JW; Howell OW; Harding KE; Sarkies P; Evans R; Bevan RJ; Hakobyan S; Harris CL; Robertson NP; Morgan BP
    Brain Pathol; 2018 Jul; 28(4):507-520. PubMed ID: 28707765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-21: Expression in oligodendrocytes and correlation with low myelin mRNAs in depression and alcoholism.
    Miguel-Hidalgo JJ; Hall KO; Bonner H; Roller AM; Syed M; Park CJ; Ball JP; Rothenberg ME; Stockmeier CA; Romero DG
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):503-514. PubMed ID: 28802862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myelin Quantification in White Matter Pathology of Progressive Multiple Sclerosis Post-Mortem Brain Samples: A New Approach for Quantifying Remyelination.
    Huitema MJD; Strijbis EMM; Luchicchi A; Bol JGJM; Plemel JR; Geurts JJG; Schenk GJ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.
    Trapp BD; Vignos M; Dudman J; Chang A; Fisher E; Staugaitis SM; Battapady H; Mork S; Ontaneda D; Jones SE; Fox RJ; Chen J; Nakamura K; Rudick RA
    Lancet Neurol; 2018 Oct; 17(10):870-884. PubMed ID: 30143361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
    Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
    Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal loss, demyelination and volume change in the multiple sclerosis neocortex.
    Carassiti D; Altmann DR; Petrova N; Pakkenberg B; Scaravilli F; Schmierer K
    Neuropathol Appl Neurobiol; 2018 Jun; 44(4):377-390. PubMed ID: 28419506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gray matter lesions and cognitive impairment in multiple sclerosis].
    Kawachi I; Saji E; Nishizawa M
    Rinsho Shinkeigaku; 2014; 54(12):1060-2. PubMed ID: 25672709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and chronic synaptic pathology in multiple sclerosis gray matter.
    Vercellino M; Marasciulo S; Grifoni S; Vallino-Costassa E; Bosa C; Pasanisi MB; Crociara P; Casalone C; Chiò A; Giordana MT; Corona C; Cavalla P
    Mult Scler; 2022 Mar; 28(3):369-382. PubMed ID: 34124960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender effect on neurodegeneration and myelin markers in an animal model for multiple sclerosis.
    Massella A; D'Intino G; Fernández M; Sivilia S; Lorenzini L; Giatti S; Melcangi RC; Calzà L; Giardino L
    BMC Neurosci; 2012 Jan; 13():12. PubMed ID: 22272832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormalities of white and grey matter in early multiple system atrophy: comparison of parkinsonian and cerebellar variants.
    Dash SK; Stezin A; Takalkar T; George L; Kamble NL; Netravathi M; Yadav R; Kumar KJ; Ingalhalikar M; Saini J; Pal PK
    Eur Radiol; 2019 Feb; 29(2):716-724. PubMed ID: 29974222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.
    Magliozzi R; Howell OW; Durrenberger P; Aricò E; James R; Cruciani C; Reeves C; Roncaroli F; Nicholas R; Reynolds R
    J Neuroinflammation; 2019 Dec; 16(1):259. PubMed ID: 31810488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligodendrocyte-Specific Deletion of
    Rajendran R; Rajendran V; Giraldo-Velasquez M; Megalofonou FF; Gurski F; Stadelmann C; Karnati S; Berghoff M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased structural white and grey matter network connectivity compensates for functional decline in early multiple sclerosis.
    Fleischer V; Gröger A; Koirala N; Droby A; Muthuraman M; Kolber P; Reuter E; Meuth SG; Zipp F; Groppa S
    Mult Scler; 2017 Mar; 23(3):432-441. PubMed ID: 27246143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain tissue and myelin volumetric analysis in multiple sclerosis at 3T MRI with various in-plane resolutions using synthetic MRI.
    Saccenti L; Andica C; Hagiwara A; Yokoyama K; Takemura MY; Fujita S; Maekawa T; Kamagata K; Le Berre A; Hori M; Hattori N; Aoki S
    Neuroradiology; 2019 Nov; 61(11):1219-1227. PubMed ID: 31209528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical impact of cerebellar grey matter pathology in multiple sclerosis.
    Damasceno A; Damasceno BP; Cendes F
    PLoS One; 2014; 9(5):e96193. PubMed ID: 24789257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of global and regional gray matter volume decrease in multiple sclerosis.
    Grothe M; Lotze M; Langner S; Dressel A
    J Neurol; 2016 Jun; 263(6):1137-45. PubMed ID: 27094570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.